Postpartum Thyroid Measures and Mood

NCT ID: NCT00565032

Last Updated: 2010-01-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

75 participants

Study Classification

OBSERVATIONAL

Study Start Date

2000-01-31

Study Completion Date

2001-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Women with abnormal serum thyroid antibody levels or abnormal TSH and/or T4 values are more likely than their normal counterparts to have higher scores on a common postpartum depression screening test.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This small pilot study was an attempt to corroborate a relationship between quantified mood and thyroid measures, using the numerical scores obtained from a common depression screen, the Edinburgh Postnatal Depression Scale (EPDS), as a continuum. Mood scores were compared with presence of thyroid autoantibodies and plasma concentrations of free T4 and TSH.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postpartum Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Over 18 years of age
* In third trimester of pregnancy when recruited
* Negative for the following drugs detected by a urine drug screen:

* Amphetamines
* Barbiturates
* Benzodiazepines
* Cocaine
* Opiates
* Phencyclidine metabolites (PCP), and tricyclic antidepressants
* Vaginal delivery
* Screened negative for major depressive disorder on the Edinburgh Postnatal Depression Scale (EPDS) at her prenatal enrollment in the study
* Receiving a score of 12 or lower out of a possible 30

Exclusion Criteria

* Under age 18
* Positive for any of the following drugs:

* Amphetamines
* Barbiturates
* Benzodiazepines
* Cocaine
* Opiates
* Phencyclidine metabolites (PCP), and tricyclic antidepressants
* Cesarean delivery
* EPDS score over 12 at prenatal screening test
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Oklahoma State University Center for Health Sciences

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gary H. Watson, PhD

Role: STUDY_DIRECTOR

Philadelphia College of Osteopathic Medicine Georgia Campus

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Oklahoma State University Center for Health Sciences Houston Park Obstetrics Clinic

Tulsa, Oklahoma, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

McCoy SJ, Beal JM, Payton ME, Stewart AL, DeMers AM, Watson GH. Postpartum thyroid measures and depressive symptomology: a pilot study. J Am Osteopath Assoc. 2008 Sep;108(9):503-7.

Reference Type DERIVED
PMID: 18806079 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

9899015

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Quetiapine Versus Trazadone in Women With Postpartum Depression
NCT06546358 NOT_YET_RECRUITING EARLY_PHASE1